Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment

Abstract excerpt

The increase in cardiovascular disease and reduced life expectancy in schizophrenia likely relate to an increased prevalence of metabolic disturbances. Such metabolic risk factors in schizophrenia may result from both symptom-related effects and aetiological factors. However, a major contributory factor is that of treatment with antipsychotic drugs. These drugs differ in effects on body weight; the underlying...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes Treatment and Management
• Share to Neurotransmitter Receptor Influence on Behavior
• Share to Schizophrenia research and treatment